Background. A positive influence of anticoagulant treatment in small cell lung cancer (SCLC)
has been sug gested by experimental and clinical data. Methods. In a multicenter clinical …

Background Small cell lung cancer (SCLC) is a chemotherapy‐responsive tumor type but
most patients ultimately experience disease progression. SCLC is associated with …

Clinical and experimental studies have suggested that unfractionated heparin (UFH) effects
malignancy progression. We reviewed all published clinical reports concerning the effects of …

OBJECTIVE To prospectively assess whether low-molecular-weight heparin (LMWH)
provides a survival benefit in patients with advanced cancer. PATIENTS AND METHODS …

PURPOSE Studies by the Veterans Administration Cooperative Studies Program and
Cancer and Leukemia Group B (CALGB) suggested that the addition of warfarin to …

The anti-tumour and anti-metastatic properties of heparins have not been tested in patients
with early stage cancer. Whether adjuvant low molecular weight heparin (LMWH) tinzaparin …

Purpose Venous thromboembolism (VTE) is common in cancer patients. Evidence has
suggested that low molecular weight heparin (LMWH) might improve survival in patients with …

The relationship between cancer and coagulopathy was suggested by Trousseau nearly
150 years ago. Later, it became more evident that oncologic patients are at a higher risk of …

Abstract Learning Objectives After completing this course, the reader will be able to: Define
characteristics of the interface between deep vein thrombosis and malignancy. Evaluate …

Background: Low‐molecular‐weight heparins (LMWH) have an antitumor effect in vitro and
in experimental animal models of malignancy. Retrospective data suggest that it might …